Why the study?
Selecting optimal transcatheter therapies for tricuspid valve disease requires careful patient selection and dedicated anatomic assessment using multi-modality imaging.
This review highlights the essential role of multimodality imaging in guiding the emerging field of transcatheter tricuspid valve interventions.
Multimodal imaging guides transcatheter tricuspid device selection in HF; leaves open optimal strategy and comparative outcomes.
Tricuspid valve disease represents a major health problem that affects a wide proportion of heart failure patients with a significant prognostic impact. In recent years an increasing number of minimally invasive and transcatheter treatments have been developed. The choice of the optimal transcatheter device therapy needs a careful patient selection and a dedicated anatomic assessment, mainly based on echocardiographic and computed tomography evaluation. Moreover, cardiac magnetic resonance has an established role in the functional assessment of right heart chambers with relevant prognostic implications. In this review we describe the role of multimodality imaging in the tricuspid valve disease assessment with an intervention-oriented perspective, from the pre-operative planning for different devices to the intraprocedural guide during transcatheter edge-to-edge repair.
No takes yet. Share an insight, caveat, or question.
Fazzari et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: